Plus D

Quick links to important sections

Plus D

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Plus D

Understanding Plus D

Plus D is a combination therapeutic agent designed to support bone health and metabolic function. It typically consists of two primary active components: a bisphosphonate (such as alendronate) and Vitamin D3 (cholecalciferol). This combination is formulated to address conditions characterized by bone density loss while simultaneously ensuring the body has adequate levels of Vitamin D to facilitate calcium absorption.

Core Components

  • Bisphosphonate Component: This class of medication works by altering the cycle of bone formation and breakdown in the body. It specifically slows down the cells that break down bone (osteoclasts), which helps to maintain bone mass and reduce the risk of fractures.
  • Vitamin D3 (Cholecalciferol): Vitamin D is a fat-soluble vitamin that plays a critical role in bone mineralization. It assists the intestines in absorbing calcium from the diet and helps the kidneys reabsorb calcium that would otherwise be excreted.

Mechanism of Action

The skeletal system is in a constant state of remodeling, where old bone is removed and new bone is created. In certain conditions, the rate of bone removal exceeds the rate of bone formation, leading to weakened or porous bones.

Plus D addresses this imbalance through a dual-action approach. While the bisphosphonate reduces bone resorption to preserve existing bone structure, the Vitamin D3 component ensures that the physiological environment is optimized for calcium utilization. Because many individuals with bone density concerns are also deficient in Vitamin D, providing both agents in a single formulation is intended to provide a more comprehensive approach to bone maintenance than using a bisphosphonate alone.

What side effects are possible with Plus D?

Possible Side Effects and Safety Information

The officially documented safety profile for Colecalciferol (Plus D) is primarily defined by the potential for risks related to the substance's powerful role in mineral homeostasis.

The most serious safety concerns, as documented in regulatory sources, revolve around Hypervitaminosis D, a state of toxicity that can lead to Progressive Hypercalcemia (elevated blood calcium). This condition may subsequently contribute to severe outcomes such as Vascular Calcification and Renal Failure.

Adverse reactions are formally categorized by frequency and the body systems affected. Common adverse reactions listed in regulatory documents include Hypercalcemia and Hypercalciuria (high calcium levels in urine). Uncommon effects may involve the gastrointestinal system, presenting as abdominal pain, nausea, vomiting, or constipation. Hypersensitivity reactions, such as rash or urticaria, are also documented.

Special Safety Considerations are defined in official labeling. For example, overdosage in pediatric populations is associated with risks to linear growth. The medicine is formally contraindicated (should not be used) in patients with pre-existing conditions like Hypercalcemia or documented Hypervitaminosis D. Furthermore, the effects of overdosage can be persistent, often lasting for two or more months after treatment has stopped, and chronic high-dose exposure is associated with the risk of organ damage.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Plus D (Colecalciferol) results in Hypervitaminosis D, leading to the core clinical syndrome of Hypercalcemia (abnormally high blood calcium). This information is based strictly on documentation from regulatory authorities, such as the FDA and EMA.

Documented Manifestations and Severe Outcomes

Classification Regulatory Findings
Common Manifestations Symptoms often include anorexia, nausea, vomiting, polyuria (frequent urination), polydipsia (excessive thirst), and generalized weakness or fatigue.
Severe Outcomes Prolonged hypercalcemia may result in serious organ toxicity, including renal impairment or failure, nephrocalcinosis (kidney calcification), and dangerous cardiac arrhythmias.
Special Consideration Regulatory documents note that infants and young children may exhibit increased sensitivity to these toxic effects.

Emergency Actions Mandated by Regulators

Immediate medical attention or contact with emergency services is required upon the suspicion of overdose due to the potential for severe, life-threatening outcomes. The medicine must be discontinued immediately. Official guidance confirms that overdose management is symptomatic and supportive, including efforts to correct fluid balance. No specific antidote is known. Close hospital monitoring of serum calcium, renal function, and cardiac activity is required.

Therapeutic Uses of Plus D

Easing Symptoms Related to Bone Health: Main Uses

Plus D, a medication, is applied in addressing conditions characterized by periods of heightened symptoms that may affect bone health. It is commonly used across conditions presenting with acute episodes that may affect bone health, and is considered relevant where functional stability becomes affected. It is applied in situations involving certain distressing symptoms linked to bone health challenges.

The medication is relevant for easing symptoms associated with these conditions. It is applied in scenarios where additional management of discomfort is required and symptoms lead to systemic or localized discomfort.

This medicine provides support that helps ease the overall symptom burden. It assists with maintaining functional stability, which supports the patient during difficult episodes and generally contributes to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relevant for symptoms that interfere with daily functioning

Eligibility and Restrictions for Use

Who Can and Cannot Use Plus D (Colecalciferol)

The eligibility for Plus D is strictly defined by regulatory documents based on a patient’s existing mineral status and organ function, not by symptoms or treatment benefits. While the medicine is broadly allowed for most adults, babies, and children, use is subject to critical exclusions.

Absolute Contraindications (Must Not Use) The medicine is formally contraindicated for patients with: Hypercalcaemia (high blood calcium), Hypervitaminosis D (excessive Vitamin D levels), and Hypersensitivity to any of the drug's components. Non-eligibility also applies to individuals with conditions such as Hypercalciuria, Nephrolithiasis (kidney stones), Severe Renal Impairment, and certain metabolic disorders like Pseudohypoparathyroidism.

Restrictions and Conditional Use Specific limitations are placed on certain groups. High-dose formulations are not recommended for pregnant women or children under 12 years. Patients with non-severe Renal Impairment, Sarcoidosis, or those who are breastfeeding must use Plus D with caution, which requires close monitoring of mineral levels as defined in the official labeling. Use in older adults also necessitates cautious dose selection.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify Colecalciferol interactions into categories based on effects on absorption, metabolism, and mineral balance. These documented interaction patterns define specific restrictions for co-administration.

Interactions Affecting Exposure (Pharmacokinetic)

Co-administration with medicines that are strong CYP3A4 inducers (e.g., Phenytoin, Rifampicin, Carbamazepine) is documented to increase the hepatic metabolism of Colecalciferol. This interaction may result in reduced systemic exposure and lower plasma concentrations of the active substance. Additionally, substances that inhibit fat absorption, such as bile acid sequestrants (e.g., Cholestyramine) and the lipase inhibitor Orlistat, significantly decrease the gastrointestinal absorption of the fat-soluble Colecalciferol. To mitigate this effect, official labeling specifies that administration must be separated in time from bile acid sequestrants.

Interactions Affecting Mineral Balance (Pharmacodynamic)

The most significant pharmacodynamic interaction involves an additive effect on calcium homeostasis. Co-administration of Thiazide diuretics (e.g., Hydrochlorothiazide) or other sources of Vitamin D or calcium supplements presents an increased risk of hypercalcemia due to reduced calcium excretion or enhanced absorption. This heightened mineral risk is also the basis for regulatory caution regarding co-administration with Cardiac Glycosides (e.g., Digoxin), as elevated calcium levels may increase the risk of cardiac arrhythmias.

Mechanism of Action

How Plus D Works (Mechanism of Action)

Plus D, containing a Vitamin D component, operates primarily after metabolic activation. The component is first converted in the liver to 25-hydroxyvitamin D, and then to the biologically active seco-steroid, 1,25-dihydroxyvitamin D (1,25( OH)2 D), predominantly in the renal tissue via 1-alpha -hydroxylase enzyme activity.

This active metabolite functions as an agonist, binding to the Vitamin D Receptor (VDR), a nuclear transcription factor located in various tissues, including the intestine, bone, and kidney. The activated 1,25( OH)2 D/ VDR complex heterodimerizes with the Retinoic X Receptor (RXR). This complex then translocates to the nucleus and binds to specific DNA sequences known as Vitamin D Responsive Elements (VDREs) in the promoter regions of target genes.

This interaction modulates the transcription of key proteins, such as Calbindin-D9k and TRPV6 (Transient Receptor Potential Vanilloid type 6) in the intestinal mucosa. The resulting cellular cascade enhances the molecular mechanisms responsible for intestinal calcium and phosphate absorption, and modulates the renal reabsorption of calcium, thereby influencing systemic calcium and phosphate levels.

Dosage and Administration Information

Dosing Instructions for Plus D

Plus D is a combination medication containing alendronate (a bisphosphonate) and cholecalciferol (Vitamin D3), primarily indicated for the treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis.

Administration

  • The tablet must be taken once weekly, exactly as prescribed.
  • Take the dose with at least 6 to 8 ounces of plain water first thing in the morning, immediately upon arising for the day, and at least 30 minutes before consuming any food, beverage (other than plain water), or other medication.
  • To minimize the risk of irritation to the upper gastrointestinal tract, the tablet must be swallowed whole. Do not chew, crush, or suck the tablet.
  • After taking the medication, remain in an upright position (sitting or standing) for at least 30 minutes and do not lie down until after the first food of the day has been eaten.

Important Considerations

  • Calcium and Vitamin D Supplementation: Patients may require additional calcium and/or Vitamin D supplementation if their dietary intake is inadequate, as determined by a healthcare provider. Vitamin D is essential for the body to absorb calcium for bone health.
  • Duration of Therapy: The optimal length of treatment with Plus D has not been definitively established. The need for continued therapy should be periodically re-evaluated by a healthcare professional.

Recent Clinical Evidence

Recent Clinical Evidence (Plus D)

Overview of Core Research

Recent, large-scale clinical research involving the combination of Calcium and Vitamin D (often referred to as 'Plus D' in supplementation trials) primarily investigates its role in bone health and potential effects on other systemic conditions.

Key Findings in Bone Health

The Women's Health Initiative (WHI) trial, a major randomized clinical trial, investigated whether daily supplementation with 1000, mg of elemental Calcium and 400, IU of Vitamin D3 was associated with a reduction in the risk of hip fracture in postmenopausal women. The results of the core intervention phase suggested that, in the overall study population, hip fracture rates were similar between the supplement group and the placebo group.

However, a subsequent analysis focusing on participants with higher adherence to the study medication did indicate a lower observed rate of hip fractures in the group receiving the supplement compared to placebo.

Research on Other Outcomes

Clinical trials have also assessed the combination's influence on various other health outcomes. No statistically significant difference was reported between the supplement and placebo groups for:

  • Colorectal cancer incidence
  • Cardiovascular disease (CVD)
  • All-cause mortality

Further meta-analyses drawing on multiple randomized controlled trials have reported that Vitamin D supplementation may be associated with a lower overall risk of all-cause mortality (ACM), although it was not consistently associated with a lower risk of specific cardiovascular morbidity or mortality outcomes like stroke or myocardial infarction (heart attack).

Frequently Asked Questions (FAQ)

Common questions about Plus D (FAQ)


Q: What kind of stomach issues are sometimes reported with Plus D?

Regulatory documents state that commonly reported gastrointestinal reactions include abdominal pain, heartburn, constipation, diarrhea, and nausea. Due to the alendronate component in the medication, severe issues such as irritation, inflammation, or ulcers of the esophagus are also reported. The purpose of the administration rules is to help minimize the risk of these upper gastrointestinal issues.


Q: Is Plus D approved for use in children?

According to the official product information, the medication is generally not recommended for use in children under 18 years of age. This is because there is insufficient data on its safety and effectiveness in treating conditions associated with pediatric osteoporosis.


Q: What does the research say about long-term use of Plus D?

Official information indicates that the optimal duration of use for the medication has not been definitively established. For patients considered to be at low risk for fracture, healthcare professionals may consider drug discontinuation after 3 to 5 years of use. Official documents state that the need for continued therapy requires periodic re-evaluation by a healthcare professional.


Q: How is Plus D absorbed by the body?

The official clinical pharmacology information indicates that the absorption of the alendronate component is relatively low. Its effectiveness is reduced if taken with food or beverages other than plain water. The cholecalciferol (Vitamin D) component is absorbed in the body as a fat-soluble vitamin.


Q: Can Plus D be used for conditions not listed on the official label?

Regulatory documents authorize the drug only for the indications outlined in the official label related to the treatment and prevention of osteoporosis in certain populations. Official prescribing information does not describe or support use for other conditions.


Q: Can Plus D cause skin rashes or itching?

According to post-marketing experience noted in official sources, allergic reactions have been reported. These can include common symptoms such as a skin rash and hives (urticaria). Severe skin reactions have been reported rarely.


Q: Is feeling dizzy a common side effect of Plus D?

Regulatory documents mention that symptoms such as dizziness and vertigo (a sensation of spinning or whirling) have been reported rarely during post-marketing surveillance. They are not listed among the commonly reported side effects based on clinical trial data.


Q: Does Plus D make you tired or sleepy?

Official reports on adverse reactions rarely include generalized symptoms related to energy levels. These may include asthenia (lack of strength) and malaise (a general feeling of being unwell). These are not common side effects.


Q: Can Plus D interact with over-the-counter pain relievers like ibuprofen?

Official labeling advises caution when the drug is taken at the same time as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or aspirin. This is due to a potential additive effect on the gastrointestinal tract that could increase irritation.


Q: Can older adults typically use Plus D safely?

According to the Geriatric Use section of the official label, no age-related differences in the efficacy or safety profiles of the drug were observed in clinical studies. Regulatory documents state that no dosage adjustment is necessary for the elderly population.


Q: Is Plus D generally considered suitable for people with kidney problems?

Regulatory documents explicitly state that the drug is not recommended for use in patients with severe kidney impairment. This is generally defined as having a creatinine clearance rate less than 35 mL/min.


Q: Does Plus D affect mood or anxiety levels?

While specific mood or anxiety changes are not listed as common side effects, rare reports in post-marketing experience have included central nervous system effects. Symptoms such as confusion have been noted in the official prescribing information.


Q: What should I do if I miss a dose of Plus D?

The official guidance for a missed weekly dose describes taking one tablet on the morning after remembrance. The guidance specifies that two tablets must not be taken on the same day, and that patients should return to their original scheduled weekly day.


Q: Is it normal to have mild headaches when first starting Plus D?

Official adverse reaction reports list headaches as a commonly reported reaction. This information is based on clinical trial data collected during the initial studies of the medication.


Q: What are the ingredients in Plus D besides the main active one?

Regulatory documents include a complete list of all ingredients, comprising the active components as well as the inactive ingredients, which are known as excipients. This full list of components is available in the Summary of Product Characteristics (SmPC) or DailyMed filing.


Q: How should Plus D be stored at home?

Official storage precautions describe keeping the medicine in its original sealed packaging. It should be kept at room temperature and protected from moisture.


Q: Are there specific symptoms that mean I should stop taking Plus D immediately?

The regulatory warning describes the need to discontinue the drug and seek immediate medical attention if signs of esophageal irritation develop, such as difficulty or pain upon swallowing, new or worsening heartburn, or chest pain.


Q: Does Plus D have different formulations (tablet, liquid, extended-release)?

Regulatory documents confirm the officially approved pharmaceutical form for Plus D is a tablet. Other forms, such as liquid or extended-release versions, are not described in the approved labeling.


Q: Can Plus D cause problems with vision?

Rarely reported events in post-marketing experience have included eye disorders. These officially noted disorders include various forms of eye inflammation, such as uveitis, scleritis, and episcleritis.


Q: What if I have an allergic reaction to Plus D?

The drug is contraindicated in patients who have a known hypersensitivity or allergic reaction to any of its components. Hypersensitivity reactions that have been reported include hives and swelling of the face or throat.


Q: What is the risk of Plus D when used during pregnancy, according to official sources?

Official regulatory sources state that Plus D is not recommended for use during pregnancy. This is based on animal studies which indicated a theoretical risk to the developing fetus, and use should therefore be avoided.


Q: Does Plus D affect fertility?

Official information derived from animal studies indicates no direct harmful effects with respect to fertility. However, it is stated that no human clinical data is available regarding the drug's effect on human fertility.


Q: What happens if I accidentally take two doses of Plus D at once?

Official information on managing a potential overdose states that symptoms may include low blood calcium (hypocalcemia) or upper gastrointestinal issues. The official information on managing a potential overdose describes drinking a full glass of milk and contacting a healthcare professional immediately.


Q: Does Plus D contain any sugar or gluten?

The official list of inactive ingredients, or excipients, provides factual information on the tablet's content. This list indicates whether the formulation contains certain common excipients like lactose (a sugar) or states if the formulation is sodium-free.

How should Plus D be stored and disposed of?

The medicine must be stored and disposed of according to official labeled requirements to maintain product integrity and ensure safety.

Storage Conditions

  • Temperature and Light: Store at controlled room temperature, typically 20 C to 25 C. The product must be protected from light and kept from freezing.
  • Container and Protection: The medicine must be kept in its original container and the container must be tightly closed to protect the contents from moisture.
  • Child Safety: It is a mandatory requirement to keep this medicine out of the sight and reach of children.

Disposal Instructions

  • Unused Product: Do not throw away any unused or expired product via wastewater or household waste. Consult a pharmacist for instructions on discarding medicines no longer needed to ensure proper environmental disposal. This procedure helps protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Plus D found in:

A-Z Index: